[1]
|
Mcglynn, K., Petrick, J. and El-Serag, H. (2021) Epidemiology of Hepatocellular Carcinoma. Hepatology (Baltimore, MD), 73, 4-13. https://doi.org/10.1002/hep.31288
|
[2]
|
Yang, J., Hainaut, P., Gores, G., et al. (2019) A Global View of Hepatocellular Carcinoma: Trends, Risk, Prevention and Management. Nature Reviews Gastroenterology & Hepatology, 16, 589-604.
https://doi.org/10.1038/s41575-019-0186-y
|
[3]
|
Yin, Z. and Li, X. (2020) Immunotherapy for Hepatocellular Carcinoma. Cancer Letters, 470, 8-17.
https://doi.org/10.1016/j.canlet.2019.12.002
|
[4]
|
Bosetti, C., Turati, F. and La Vecchia, C. (2014) Hepatocellular Carcinoma Epidemiology. Best Practice & Research Clinical Gastroenterology, 28, 753-770. https://doi.org/10.1016/j.bpg.2014.08.007
|
[5]
|
Rinella, M. (2015) Nonalcoholic Fatty Liver Disease: A Systematic Review. JAMA, 313, 2263-2273.
https://doi.org/10.1001/jama.2015.5370
|
[6]
|
Dyson, J., Jaques, B., Chattopadyhay, D., et al. (2014) Hepatocellular Cancer: The Impact of Obesity, Type 2 Diabetes and a Multidisciplinary Team. Journal of Hepatology, 60, 110-117. https://doi.org/10.1016/j.jhep.2013.08.011
|
[7]
|
Naruse, K., Tang, W. and Makuuch, M. (2007) Artificial and Bioartificial Liver Support: A Review of Perfusion Treatment for Hepatic Failure Patients. World Journal of Gastroenterology, 13, 1516-1521.
https://doi.org/10.3748/wjg.v13.i10.1516
|
[8]
|
Green, C., Pramfalk, C., Morten, K., et al. (2015) From Whole Body to Cellular Models of Hepatic Triglyceride Metabolism: Man Has Got to Know His Limitations. American Journal of Physiology Endocrinology and Metabolism, 308, E1-E20. https://doi.org/10.1152/ajpendo.00192.2014
|
[9]
|
Kato, A., Ando, K., Tamura, G., et al. (1971) Effects of Some Fatty Acid Esters on the Viability and Transplantability of Ehrlich Ascites Tumor Cells. Cancer Research, 31, 501-504.
|
[10]
|
Mcgee, R. and Spector, A. (1974) Short-Term Effects of Free Fatty Acids on the Regulation of Fatty Acid Biosynthesis in Ehrlich Ascites Tumor Cells. Cancer Research, 34, 3355-3362.
|
[11]
|
Chen, Y., Liu, B., Tang, D., et al. (1992) Fatty Acid Modulation of Tumor Cell-Platelet-Vessel Wall Interaction. Cancer Metastasis Reviews, 11, 389-409. https://doi.org/10.1007/BF01307189
|
[12]
|
Honn, K., Nelson, K., Renaud, C., et al. (1992) Fatty Acid Modulation of Tumor Cell Adhesion to Microvessel Endothelium and Experimental Metastasis. Prostaglandins, 44, 413-429. https://doi.org/10.1016/0090-6980(92)90137-I
|
[13]
|
Feldstein, A. (2010) Novel Insights into the Pathophysiology of Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease, 30, 391-401. https://doi.org/10.1055/s-0030-1267539
|
[14]
|
Adams, L., Lymp, J., St. Sauver, J., et al. (2005) The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study. Gastroenterology, 129, 113-121. https://doi.org/10.1053/j.gastro.2005.04.014
|
[15]
|
Yang, Y., Yang, X., Lin, Y., et al. (2020) LASS2 Regulates Hepatocyte Steatosis by Interacting with NDUFS2/OXPHOS Related Proteins. Biochemical and Biophysical Research Communications, 526, 871-879.
https://doi.org/10.1016/j.bbrc.2020.02.166
|
[16]
|
Yin, F., Sharen, G., Yuan, F., et al. (2017) TIP30 Regulates Lipid Metabolism in Hepatocellular Carcinoma by Regulating SREBP1 through the Akt/mTOR Signaling Pathway. Oncogenesis, 6, e347.
https://doi.org/10.1038/oncsis.2017.49
|
[17]
|
Calle, E., Rodriguez, C., Walker-Thurmond, K., et al. (2003) Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults. The New England Journal of Medicine, 348, 1625-1638.
https://doi.org/10.1056/NEJMoa021423
|
[18]
|
Davila, J., Morgan, R., Shaib, Y., et al. (2005) Diabetes Increases the Risk of Hepatocellular Carcinoma in the United States: A Population Based Case Control Study. Gut, 54, 533-539. https://doi.org/10.1136/gut.2004.052167
|
[19]
|
Savage, D. and Semple, R. (2010) Recent Insights into Fatty Liver, Metabolic Dyslipidaemia and Their Links to Insulin Resistance. Current Opinion in Lipidology, 21, 329-336. https://doi.org/10.1097/MOL.0b013e32833b7782
|
[20]
|
Chalasani, N., Younossi, Z., Lavine, J., et al. (2012) The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology (Baltimore, MD), 55, 2005-2023.
https://doi.org/10.1002/hep.25762
|
[21]
|
Day, C. and James, O. (1998) Steatohepatitis: A Tale of Two “Hits”? Gastroenterology, 114, 842-845.
https://doi.org/10.1016/S0016-5085(98)70599-2
|
[22]
|
Warburg, O. (1956) On the Origin of Cancer Cells. Science (New York, NY), 123, 309-314.
https://doi.org/10.1126/science.123.3191.309
|
[23]
|
Simon, T., King, L., Chong, D., et al. (2018) Diabetes, Metabolic Comorbidities, and Risk of Hepatocellular Carcinoma: Results from Two Prospective Cohort Studies. Hepatology (Baltimore, MD), 67, 1797-806.
https://doi.org/10.1002/hep.29660
|
[24]
|
Luo, F., Liu, X., Ling, M., et al. (2016) The lncRNA MALAT1, Acting through HIF-1α Stabilization, Enhances Arsenite-Induced Glycolysis in Human Hepatic L-02 Cells. Biochimica et Biophysica Acta, 1862, 1685-1695.
https://doi.org/10.1016/j.bbadis.2016.06.004
|
[25]
|
Wei, S., Fan, Q., Yang, L., et al. (2017) Promotion of Glycolysis by HOTAIR through GLUT1 Upregulation via mTOR Signaling. Oncology Reports, 38, 1902-1908. https://doi.org/10.3892/or.2017.5840
|
[26]
|
Huang, Y., Cai, X., Qiu, M., et al. (2014) Prediabetes and the Risk of Cancer: A Meta-Analysis. Diabetologia, 57, 2261-2269. https://doi.org/10.1007/s00125-014-3361-2
|
[27]
|
Yan, Y., Xu, H., Zhang, L., et al. (2019) RRAD Suppresses the Warburg Effect by Downregulating ACTG1 in Hepatocellular Carcinoma. OncoTargets and Therapy, 12, 1691-1703. https://doi.org/10.2147/OTT.S197844
|
[28]
|
Apetoh, L., Ghiringhelli, F., Tesniere, A., et al. (2007) Toll-Like Receptor 4-Dependent Contribution of the Immune System to Anticancer Chemotherapy and Radiotherapy. Nature Medicine, 13, 1050-1059.
https://doi.org/10.1038/nm1622
|
[29]
|
Chowdhury, T.A. (2010) Diabetes and Cancer. QJM: Monthly Journal of the Association of Physicians, 103, 905-915.
https://doi.org/10.1093/qjmed/hcq149
|
[30]
|
Jemal, A., Bray, F., Center, M., et al. (2011) Global Cancer Statistics. CA: A Cancer Journal for Clinicians, 61, 69-90.
https://doi.org/10.3322/caac.20107
|
[31]
|
Giovannucci, E., Harlan, D., Archer, M., et al. (2010) Diabetes and Cancer: A Consensus Report. Diabetes Care, 33, 1674-1685. https://doi.org/10.2337/dc10-0666
|
[32]
|
Maiuri, M., Tasdemir, E., Criollo, A., et al. (2009) Control of Autophagy by Oncogenes and Tumor Suppressor Genes. Cell Death and Differentiation, 16, 87-93. https://doi.org/10.1038/cdd.2008.131
|
[33]
|
Vigneri, P., Frasca, F., Sciacca, L., et al. (2009) Diabetes and Cancer. Endocrine-Related Cancer, 16, 1103-1123.
https://doi.org/10.1677/ERC-09-0087
|
[34]
|
Mccullough, M., Patel, A., Kushi, L., et al. (2011) Following Cancer Prevention Guidelines Reduces Risk of Cancer, Cardiovascular Disease, and All-Cause Mortality. Cancer Epidemiology, Biomarkers & Prevention, 20, 1089-1097.
https://doi.org/10.1158/1055-9965.EPI-10-1173
|
[35]
|
Willett, W. (2008) Nutrition and Cancer: The Search Continues. Nutrition and Cancer, 60, 557-559.
https://doi.org/10.1080/01635580802380370
|
[36]
|
Di Masi, A., Leboffe, L., De Marinis, E., et al. (2015) Retinoic Acid Receptors: From Molecular Mechanisms to Cancer Therapy. Molecular Aspects of Medicine, 41, 1-115. https://doi.org/10.1016/j.mam.2014.12.003
|
[37]
|
Yan, T., Wu, H., Zhang, H., et al. (2010) Oncogenic Potential of Retinoic Acid Receptor-Gamma in Hepatocellular Carcinoma. Cancer Research, 70, 2285-2295. https://doi.org/10.1158/0008-5472.CAN-09-2968
|
[38]
|
Matsumoto, K., Okano, J., Nagahara, T., et al. (2006) Apoptosis of Liver Cancer Cells by Vitamin K2 and Enhancement by MEK Inhibition. International Journal of Oncology, 29, 1501-1508. https://doi.org/10.3892/ijo.29.6.1501
|
[39]
|
Yang, C. and Han, L. (2010) Knockdown of Beclin 1 Inhibits Vitamin K3-Induced Autophagy, But Promotes Apoptosis of Human Hepatoma SMMC-7721 Cells. Molecular Medicine Reports, 3, 801-807.
https://doi.org/10.3892/mmr.2010.347
|
[40]
|
Chun, Y., Lee, B., Yang, S., et al. (2001) Induction of Cytochrome P450 1A1 Gene Expression by a Vitamin K3 Analog in Mouse Hepatoma Hepa-1c1c7 Cells. Molecules and Cells, 12, 190-196.
|
[41]
|
Wang, J., Abnet, C., Chen, W., et al. (2013) Association between Serum 25(OH) Vitamin D, Incident Liver Cancer and Chronic Liver Disease Mortality in the Linxian Nutrition Intervention Trials: A Nested Case-Control Study. British Journal of Cancer, 109, 1997-2004. https://doi.org/10.1038/bjc.2013.546
|
[42]
|
Wibaux, C., Legroux-Gerot, I., Dharancy, S., et al. (2011) Assessing Bone Status in Patients Awaiting Liver Transplantation. Joint Bone Spine, 78, 387-391. https://doi.org/10.1016/j.jbspin.2011.03.001
|
[43]
|
Calvisi, D., Ladu, S., Hironaka, K., et al. (2004) Vitamin E Down-Modulates iNOS and NADPH Oxidase in c-Myc/TGF-Alpha Transgenic Mouse Model of Liver Cancer. Journal of Hepatology, 41, 815-822.
https://doi.org/10.1016/j.jhep.2004.07.030
|
[44]
|
Factor, V., Laskowska, D., Jensen, M., et al. (2000) Vitamin E Reduces Chromosomal Damage and Inhibits Hepatic Tumor Formation in a Transgenic Mouse Model. Proceedings of the National Academy of Sciences of the United States of America, 97, 2196-2201. https://doi.org/10.1073/pnas.040428797
|
[45]
|
Zhang, W., Shu, X., Li, H., et al. (2012) Vitamin Intake and Liver Cancer Risk: A Report from Two Cohort Studies in China. Journal of the National Cancer Institute, 104, 1174-1182. https://doi.org/10.1093/jnci/djs277
|